- Home
- -
- About us
Hera-MI’s history & value proposition
Emerging from the field of ITS – Industries and Technologies of Health – Hera-MI, established in Nantes since 2017, asserts itself today as one of the French startups in MedTech focused on innovation in health and artificial intelligence. Its commitment to health carries a general interest.
At the helm of Hera-MI is Sylvie Davila, a Ph.D. in biology, holder of an Executive MBA, and an expert in medical imaging. She takes on the role of founder and president of the company.
Hera-MI focuses on research and development, design, as well as the marketing of AI-based medical devices. These software solutions aim to facilitate the radiological diagnosis of cancer, improving the quality and precision of image interpretation. At the same time, patients benefit from an optimized analysis.
Hera-MI’s first achievement is Breast-SlimView®, a patented decision-support software solution that relies on artificial intelligence and image processing for the radiological diagnosis of breast cancer.
Hera-MI distributes Breast-SlimView® internationally, either through direct sales to radiologists or through a network of commercial partners.
Origin of « Hera-MI » name
The name ‘‘Hera-MI’’ results from the combination of ‘’Hera’’ and ‘’MI’’.
In Greek mythology, “Hera” is the protective goddess of women, life and family & “MI” refers to “Medical Imaging”.
Hera-MI’s vision & mission
Hera-MI focuses its research on artificial intelligence applied to medical imaging, with a particular emphasis on cancer diagnosis.
The company’s objective is to address the future healthcare challenges by enhancing the healthcare system experience through AI.
In this context, Hera-MI is developing software solutions to support medical decision-making, benefiting radiologists, breast specialists, and patients.
In this regard, Hera-MI has introduced a pioneering medical device, Breast-SlimView®. This is a patented decision support software dedicated to 2D and 3D mammography (tomosynthesis), specifically designed for breast cancer screening.
Awards
- Winner of “Graines de boss” 2022
- Winner of the 6ème Sommet des start-up & innovation (Challenges)
- Sylvie Davila, Founder & CEO of Hera-MI is the winner, category Open innovation of the tremplin des startups (Assises de la parité 2021)
- Hera-MI, winner i-Nov 2021 (BPI France)
- Prize coup de coeur de l’innovation en imagerie médicale 2021 (JFR)
- Prize Health, 10 000 startups 2021 pour changer le monde Grand Ouest (La Tribune)
- First prize of the concours International Pitch Challenge 2019 (CCI des Pays de la Loire)
- Winner of the Start West 2018, prize Région Pays de la Loire (Atlanpole Biotherapies)
Executive Committee
Sylvie DAVILA, PhD/MBA – Founder & CEO
Sylvie Davila, CEO of Hera-MI is a Doctor in Biology and a graduate from an Executive MBA. Sylvie has over 16 years of experience in medical imaging, in particular in clinical trials. Radiology product specialist at Siemens Healthcare and Hitachi Medical Systems, Sylvie also held the position of Vice President of Sales & Marketing at Keosys Medical Imaging for 6 years.
Mickael TARDY – CSO
Mickael graduated from Ecole Centrale de Nantes and has 12 years of experience in IT development applied to medical imaging, especially in clinical trials imaging for which he used to work using the Agile method. Mickael is currently working on a CIFRE thesis in Artificial Intelligence applied to medical imaging.
Alexandre BALABAN – Chief Technical Officer
Alexandre holds the position of Technical Director at Hera-MI, where he leverages his computer engineering skills and draws upon an impressive 19-year experience in the field of medical imaging. This expertise spans the conduct of clinical studies and the certification of Medical Devices products. Additionally, Alexandre possesses a strong background in applying Agile methodology to effectively guide Research & Development activities.
